| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |